FOLEY HOAG ADVISES ARKEABIO IN $26.5M SERIES A FUNDING ROUND
June 13, 2024
June 13, 2024
BOSTON, Massachusetts, June 13 -- Foley Hoag, a law firm, issued the following news:
Foley Hoag LLP advised ArkeaBio, an ag-biotech start-up developing a vaccine to reduce livestock methane emissions, in closing a $26.5 million Series A financing round led by current investor Breakthrough Energy Ventures.
ArkeaBio will use the funding for research and development related to its vaccine, which will provide an innovative, cost-effective, and scalable solution to reduce th . . .
Foley Hoag LLP advised ArkeaBio, an ag-biotech start-up developing a vaccine to reduce livestock methane emissions, in closing a $26.5 million Series A financing round led by current investor Breakthrough Energy Ventures.
ArkeaBio will use the funding for research and development related to its vaccine, which will provide an innovative, cost-effective, and scalable solution to reduce th . . .